Saturday, June 1st
12:00 am | Together with Bencard Germany ClinCompetence Cologne presents an interim analysis of a 5 years AIT cohort study in Children, adolescents and adults
TAPAS – a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy R. Mösges (Cologne, Germany)
Sunday, June 2nd
08:58 am | ClinCompetence Cologne presents a new methodology to improve ePRO data In clinical trials
80% reduction of required sample size in clinical trials by eDiary monitoring
R. Mösges (Cologne, Germany)
12:00 am | Together with Inmunotek, Spain ClinCompetence Cologne presents safety and tolerability data of co-seasonal birch AIT with mannan-conjugated allergoids
Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
R. Mösges (Cologne, Germany)
12:00 am | Together with Leti, Germany ClinCompetence Cologne presents safety and tolerability data of cat AIT with depigmented allergoids
Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions R. Mösges (Cologne, Germany)
